Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,737 | 21,259 | 16,617 | 16,019 | 20,051 |
| TOTAL | $118,003 | $22,707 | $18,016 | $16,564 | $20,787 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 806 | 845 | 883 | 1,201 | 957 |
| TOTAL | $806 | $845 | $883 | $1,201 | $957 |
| Total Assets | $118,809 | $23,552 | $18,899 | $17,765 | $21,744 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,143 | 977 | 1,469 | 1,376 | 871 |
| Accrued Expenses | 3,042 | 3,273 | 3,607 | 2,778 | 2,731 |
| TOTAL | $5,858 | $7,551 | $9,000 | $7,317 | $7,341 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,633 | 3,222 | 3,807 | 3,062 | 3,640 |
| Other Non-Current Liabilities | 0 | 301 | 301 | 53 | 91 |
| TOTAL | $N/A | $301 | $301 | $53 | $91 |
| Total Liabilities | $5,858 | $7,852 | $9,301 | $7,370 | $7,432 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,464 | 1,117 | 996 | 770 | 769 |
| Common Shares | 49 | 22 | 17 | 15 | 15 |
| Retained earnings | -82,797 | -80,240 | -75,845 | -70,310 | -65,572 |
| TOTAL | $112,951 | $15,700 | $9,598 | $10,395 | $14,312 |
| Total Liabilities And Equity | $118,809 | $23,552 | $18,899 | $17,765 | $21,744 |